EDEN has the ability to identify novel, bacterial vaccine antigens that trigger robust, protective immune responses against a broad range of bacterial sub-strains in a matter of hours.

Taking advantage of the rapid increase in big data from modern, high throughput sequencing studies, EDEN utilizes proteomes from clinically relevant pathogen strains as input. With specialized machine learning methods, EDEN targets immune evasion strategies of bacteria and outputs a list of proteins ranked by their capability to induce both a comprehensive and defensive immune response.

Home page of this offering   provided by Evaxion Biotech